Healthy volunteers needed to test experimental Injection's safety

NCT ID NCT07474545

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a single dose of an experimental drug called KL0011034 in 76 healthy Chinese volunteers aged 18-45. The main goal is to check for side effects and how the drug moves through the body. Participants are randomly assigned to receive the drug, a placebo, or an active comparator. No direct health benefit is expected, but results will guide future research.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Third XIANGYA Hospital of Central South University

    RECRUITING

    Changsha, Hunan, 410205, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.